Ivermectin Disappoints in Mild COVID-19

(MedPage Today) -- COVID-19 patients treated in a randomized trial with the anti-parasitic drug ivermectin did no better than a placebo group, Colombian researchers said.
Median time to recovery among mild COVID-19 patients in the ivermectin group...